Phenolic acid concentrations in the lumbar cerebrospinal fluid of Parkinsonian patients treated with l-dopa

AUTOR(ES)

Pullar, I. A.

RESUMO

The acid metabolites of dopamine and 5-hydroxytryptamine were estimated in the lumbar cerebrospinal fluid (CSF) of Parkinsonian patients both before and during treatment with l-dopa, the amino acid precursor of dopamine. An attempt was made to relate clinical improvement to the biochemical results. The dopamine metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, showed increases related to the dose of l-dopa, the increase in homovanillic acid concentration being proportionately greater than that of 3,4-dihydroxyphenylacetic acid. The concentration of the 5-hydroxytryptamine metabolite, 5-hydroxyindol-3ylacetic acid, was unaltered by the drug. Clinical improvement, which in the early stages was evident particularly in the bradykinesia, was found to occur at doses of l-dopa greater than 1·5 g/day. Effective doses of l-dopa gave rise to concentrations of dopamine metabolites in the CSF which were greater than normal. Possible implications of these findings are discussed.

Documentos Relacionados

• The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa.
• Plasma concentrations of L-dopa and 3-methoxydopa and improvement in clinical ratings and motor performance in patients with Parkinsonism treated with L-dopa alone or in combination with amantadine.
• Psychiatric aspects in Parkinsonism treated with L-dopa
• Interactions of L-dopa and amantadine in patients with Parkinsonism
• Analysis of l-dopa induced dyskinesias in 51 patients with Parkinsonism